Prognostic markers in quadruple negative breast cancer

Authors

  • Galina Yaneva Department of Biology, Faculty of Pharmacy, Medical University ‘Professor Paraskev Stoyanov’, Varna
  • Tsonka Dimitrova Department of Biology, Faculty of Pharmacy, Medical University ‘Professor Paraskev Stoyanov’, Varna
  • Stoyan Stoyanov Department of Biology, Faculty of Pharmacy, Medical University ‘Professor Paraskev Stoyanov’, Varna
  • Nikoleta Ivanova Department of Biology, Faculty of Pharmacy, Medical University ‘Professor Paraskev Stoyanov’, Varna
  • Galina Nenkova Department of Biology, Faculty of Pharmacy, Medical University ‘Professor Paraskev Stoyanov’, Varna
  • Djeni Cherneva Department of Biology, Faculty of Pharmacy, Medical University ‘Professor Paraskev Stoyanov’, Varna
  • Petya Boycheva Department of Biology, Faculty of Pharmacy, Medical University ‘Professor Paraskev Stoyanov’, Varna
  • Dobri Ivanov Department of Biology, Faculty of Pharmacy, Medical University ‘Professor Paraskev Stoyanov’, Varna

Keywords:

quadruple negative breast cancer, triple negative breast cancer, androgen receptor expression, biomarkers, prognosis

Abstract

Quadruple-negative breast cancer (QNBC) presents with negative expression of estrogen, progesterone, and androgen receptors and of human epidermal growth factor receptor 2. This BC subtype has the worst prognosis. In QNBC, there is a greater paucity of prognostic biomarkers than in androgen receptors-positive triple negative BC (TNBC). Absent androgen receptor expression confers a more aggressive QNBC course and correlates with the expression of cancer stem cell phenotype, COX-2, and basal markers such as CK5 and nestin. Basal-like phenotype is significantly associated with adverse prognostic markers including high KI-67, COX-2 expression, and cancer stem cell phenotype. Engrailed-1 expression is associated with unfavorable overall survival in QNBC patients. Non-coding ribonucleic acids play a significant role in BC tumourigenesis by virtue of their oncogenic and tumour-suppressive properties. The identification of QNBC-specific circulating microribonucleic acids may improve tumour detection and prognosis. There is an obvious necessity to intensify the problem-oriented interdisciplinary research on the hot topic of prognostic biomarkers of QNBC.

Downloads

Published

2023-01-10

How to Cite

[1]
Yaneva, G., Dimitrova, T., Stoyanov, S. , Ivanova, N. , Nenkova, G., Cherneva, D. , Boycheva, P. and Ivanov, D. 2023. Prognostic markers in quadruple negative breast cancer. Journal of BioScience and Biotechnology. 11, 2 (Jan. 2023), 71–75.

Issue

Vol. 11 No. 2 (2022)

Section

Cellular and Molecular Biology

License

Copyright (c) 2022 Galina Yaneva, Tsonka Dimitrova, Stoyan Stoyanov, Nikoleta Ivanova, Galina Nenkova, Djeni Cherneva, Petya Boycheva, Dobri Ivanov

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.

Authors of articles published in Journal of BioScience and Biotechnology retain the copyright of their articles. The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author.

Authors retain the following rights:
  • copyright, and other proprietary rights relating to the article, such as patent rights;
  • the right to use the substance of the article in future own works, including lectures and books;
  • the right to reproduce the article for own purposes, provided the copies are not offered for sale;
  • the right to self-archive the article.